Predicting amyloid PET and tau PET stages with plasma biomarkers
Sign Up to like & getrecommendations! Published in 2023 at "Brain"
DOI: 10.1093/brain/awad042
Abstract: Abstract Staging the severity of Alzheimer’s disease pathology using biomarkers is useful for therapeutic trials and clinical prognosis. Disease staging with amyloid and tau PET has face validity; however, this would be more practical with… read more here.
Keywords: plasma biomarkers; tau pet; pet stages; pet ... See more keywords